CD4 and CD8 monoclonal antibody therapy in canine renal allografts.

Therapy with CD4 and CD8 monoclonal antibodies was evaluated in dogs which received double-haplotype MHC-mismatched renal allografts. Neither CD4 nor CD8 monoclonal antibodies given alone prolonged allografts survival (creatinine > or = 300 micromol/l) beyond 7 days. However, combined therapy...

Descripció completa

Dades bibliogràfiques
Autors principals: Watson, C, Cobbold, S, Davies, H, Rebello, P, Waldmann, H, Calne, R, Metcalfe, S
Format: Journal article
Idioma:English
Publicat: 1994